Germline deletion of Rgs2 and/or Rgs5 in male mice does not exacerbate left ventricular remodeling induced by subchronic isoproterenol infusion
2025

Impact of Rgs2 and Rgs5 Deletion on Heart Function in Mice

Sample size: 8 publication 10 minutes Evidence: moderate

Author Information

Author(s): Dahlen Shelby, Mohanty Ipsita, Sun Bo, Nallapaneni Sanjana, Osei‐Owusu Patrick

Primary Institution: Case Western Reserve University School of Medicine

Hypothesis

Does the deletion of Rgs2 and/or Rgs5 exacerbate left ventricular remodeling induced by isoproterenol infusion in male mice?

Conclusion

The deletion of Rgs2 and/or Rgs5 does not worsen left ventricular remodeling caused by isoproterenol infusion in male mice.

Supporting Evidence

  • Rgs2 KO and Rgs2/5 dbKO mice showed LV dilatation at baseline, which was unchanged by ISO.
  • ISO induced cardiac hypertrophy and interstitial fibrosis in Rgs2/5 dbKO mice without increasing cardiomyocyte size.
  • Single Rgs2 and Rgs5 KO mice had markedly increased CD45+ cells, indicating immune cell presence.

Takeaway

Scientists studied mice to see if removing certain genes made their hearts worse when given a medicine. They found that it didn't make the hearts worse.

Methodology

The study involved male mice with genetic modifications and assessed heart function through echocardiography after isoproterenol infusion.

Potential Biases

Potential compensatory mechanisms due to genetic modifications may influence results.

Limitations

The study only included male mice, which limits understanding of sex differences in heart function.

Participant Demographics

Male mice aged 2-6 months.

Statistical Information

P-Value

<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.14814/phy2.70178

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication